{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:36:56Z","timestamp":1782275816508,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Thai Research Funding","award":["MRG6080047"],"award-info":[{"award-number":["MRG6080047"]}]},{"name":"Ratchadaphiseksomphot Endownment fund","award":["GSTAR 59-005-30-001"],"award-info":[{"award-number":["GSTAR 59-005-30-001"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.phymed.2019.153133","type":"journal-article","created":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T11:59:52Z","timestamp":1573473592000},"page":"153133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["NADPH: Quinone oxidoreductase 1 (NQO1) mediated anti-cancer effects of plumbagin in endocrine resistant MCF7 breast cancer cells"],"prefix":"10.1016","volume":"66","author":[{"given":"Nalinee","family":"Pradubyat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1759-5974","authenticated-orcid":false,"given":"Nithidol","family":"Sakunrangsit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apiwat","family":"Mutirangura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1215-5750","authenticated-orcid":false,"given":"Wannarasmi","family":"Ketchart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2019.153133_bib0001","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/jcb.21966","article-title":"Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-kappaB and Bcl-2","volume":"105","author":"Ahmad","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.phymed.2019.153133_bib0002","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.pharep.2017.02.006","article-title":"Nrf2 and NF-kappaB modulation by Plumbagin attenuates functional, behavioural and biochemical deficits in rat model of neuropathic pain","volume":"69","author":"Arruri","year":"2017","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.phymed.2019.153133_bib0003","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1073\/pnas.052706799","article-title":"NQO1 stabilizes p53 through a distinct pathway","volume":"99","author":"Asher","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phymed.2019.153133_bib0004","first-page":"1569","article-title":"Plumbagin, a natural naphthoquinone, inhibits the growth of esophageal squamous cell carcinoma cells through inactivation of STAT3","volume":"42","author":"Cao","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.phymed.2019.153133_bib0005","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.3892\/mmr.2017.7222","article-title":"Plumbagin induces apoptosis in human osteosarcoma through ROS generation, endoplasmic reticulum stress and mitochondrial apoptosis pathway","volume":"16","author":"Chao","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.phymed.2019.153133_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2019.07.017","article-title":"Natural product-inspired profluorophores for imaging NQO1 activity in tumour tissues","author":"Cheng","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.phymed.2019.153133_bib0007","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0006-2952(91)90284-C","article-title":"High levels of expression of the NAD(P)H:quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same origin","volume":"42","author":"Cresteil","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phymed.2019.153133_bib0008","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.fct.2018.11.040","article-title":"Plumbagin from a tropical pitcher plant (Nepenthes alata Blanco) induces apoptotic cell death via a p53-dependent pathway in MCF-7 human breast cancer cells","volume":"123","author":"De","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.phymed.2019.153133_bib0009","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature10189","article-title":"Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis","volume":"475","author":"DeNicola","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2019.153133_bib0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00008571-200201000-00005","article-title":"Clinical significance of a NAD(P)H: quinone oxidoreductase 1 polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin C","volume":"12","author":"Fleming","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.phymed.2019.153133_bib0011","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.lfs.2015.12.017","article-title":"Overexpression of NAD(P)H:quinone oxidoreductase 1 (NQO1) and genomic gain of the NQO1 locus modulates breast cancer cell sensitivity to quinones","volume":"145","author":"Glorieux","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.phymed.2019.153133_bib0012","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.3892\/mmr.2017.6234","article-title":"Plumbagin prevents osteoarthritis in human chondrocytes through Nrf-2 activation","volume":"15","author":"Guo","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.phymed.2019.153133_bib0013","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1158\/1940-6207.CAPR-14-0231","article-title":"Plumbagin inhibits prostate carcinogenesis in intact and castrated PTEN knockout mice via targeting PKCepsilon, Stat3, and epithelial-to-mesenchymal transition markers","volume":"8","author":"Hafeez","year":"2015","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.phymed.2019.153133_bib0014","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1021\/np3000409","article-title":"Plumbagin induces apoptosis in Her2-overexpressing breast cancer cells through the mitochondrial-mediated pathway","volume":"75","author":"Kawiak","year":"2012","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.phymed.2019.153133_bib0015","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.5114\/aoms.2016.64768","article-title":"Plumbagin protects against hydrogen peroxide-induced neurotoxicity by modulating Nf-kappaB and Nrf-2","volume":"14","author":"Kuan-Hong","year":"2018","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.phymed.2019.153133_bib0016","doi-asserted-by":"crossref","first-page":"e45023","DOI":"10.1371\/journal.pone.0045023","article-title":"The natural anticancer agent plumbagin induces potent cytotoxicity in MCF-7 human breast cancer cells by inhibiting a PI-5 kinase for ROS generation","volume":"7","author":"Lee","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.phymed.2019.153133_bib0017","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5567\/pharmacologia.2012.57.60","article-title":"Investigation of plumbagin content in plumbago indica linn. Grown under Different Growing Systems","volume":"3","author":"Lenora","year":"2012","journal-title":"Pharmacologia"},{"key":"10.1016\/j.phymed.2019.153133_bib0018","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1158\/1541-7786.MCR-15-0207-T","article-title":"Depleting tumor-nqo1 potentiates anoikis and inhibits growth of NSCLC","volume":"14","author":"Madajewski","year":"2016","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.phymed.2019.153133_bib0019","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1476-4598-10-107","article-title":"Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4","volume":"10","author":"Manu","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phymed.2019.153133_bib0020","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.biopha.2018.02.052","article-title":"Plumbagin ameliorates memory dysfunction in streptozotocin induced Alzheimer\u2019s disease via activation of Nrf2\/are pathway and inhibition of beta-secretase","volume":"101","author":"Nakhate","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phymed.2019.153133_bib0021","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4161\/cbt.4.1.1382","article-title":"Efficacy of beta-lapachone in pancreatic cancer treatment: exploiting the novel, therapeutic target NQO1","volume":"4","author":"Ough","year":"2005","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.phymed.2019.153133_bib0022","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/med.20235","article-title":"Perspectives on medicinal properties of plumbagin and its analogs","volume":"32","author":"Padhye","year":"2012","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.phymed.2019.153133_bib0023","first-page":"1601","article-title":"Plumbagin induces G2\/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K\/Akt\/mTOR-mediated pathways in human tongue squamous cell carcinoma cells","volume":"9","author":"Pan","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.phymed.2019.153133_bib0024","first-page":"5511","article-title":"Plumbagin suppresses epithelial to mesenchymal transition and stemness via inhibiting Nrf2-Mediated signaling pathway in human tongue squamous cell carcinoma cells","volume":"9","author":"Pan","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.phymed.2019.153133_bib0025","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1021\/cb4005832","article-title":"Efficient NQO1 substrates are potent and selective anticancer agents","volume":"8","author":"Parkinson","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.phymed.2019.153133_bib0026","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0009-2797(00)00199-X","article-title":"NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms","volume":"129","author":"Ross","year":"2000","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.phymed.2019.153133_bib0026a","doi-asserted-by":"crossref","unstructured":"Sakunrangsit, N., Ketchart, W., 2019. Plumbagin inhibits cancer stem-likecells, angiogenesis and suppresses cell proliferation and invasion by targeting Wnt\/\u03b2-catenin pathway in endocrine resistant breast cancer. Pharmacol. Res., doi:https:\/\/doi.org\/10.1016\/j.phrs.2019.104517.","DOI":"10.1016\/j.phrs.2019.104517"},{"key":"10.1016\/j.phymed.2019.153133_bib0027","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/ptr.5702","article-title":"Plumbagin enhances tamoxifen sensitivity and inhibits tumor invasion in endocrine resistant breast cancer through EMT regulation","volume":"30","author":"Sakunrangsit","year":"2016","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phymed.2019.153133_bib0028","first-page":"2065","article-title":"Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors","volume":"4","author":"Siegel","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2019.153133_bib0029","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.bcp.2011.12.017","article-title":"NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones","volume":"83","author":"Siegel","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phymed.2019.153133_bib0030","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1471-4159.2009.06552.x","article-title":"Plumbagin, a novel Nrf2\/are activator, protects against cerebral ischemia","volume":"112","author":"Son","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phymed.2019.153133_bib0031","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/mc.20031","article-title":"Plumbagin induces reactive oxygen species, which mediate apoptosis in human cervical cancer cells","volume":"40","author":"Srinivas","year":"2004","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.phymed.2019.153133_bib0032","doi-asserted-by":"crossref","first-page":"e18695","DOI":"10.1371\/journal.pone.0018695","article-title":"Apoptosis inducing effect of plumbagin on colonic cancer cells depends on expression of COX-2","volume":"6","author":"Subramaniya","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.phymed.2019.153133_bib0033","first-page":"52","article-title":"Quantitative determination of plumbagin in Plumbago indica L. root extract using reverse phase-high performance liquid chromatography","volume":"12","author":"Sukkasem","year":"2016","journal-title":"Isan J. Pharm. Sci."},{"key":"10.1016\/j.phymed.2019.153133_bib0034","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1074\/jbc.M110.193276","article-title":"E3 ligase STUB1\/CHIP regulates NAD(P)H:quinone oxidoreductase 1 (NQO1) accumulation in aged brain, a process impaired in certain Alzheimer disease patients","volume":"286","author":"Tsvetkov","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2019.153133_bib0035","doi-asserted-by":"crossref","first-page":"844","DOI":"10.4103\/0250-474X.49142","article-title":"A reverse phase HPLC-UV and HPTLC methods for determination of plumbagin in plumbago indica and plumbago zeylanica","volume":"70","author":"Unnikrishnan","year":"2008","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.phymed.2019.153133_bib0036","first-page":"537","article-title":"Plumbagin induces cell cycle arrest and autophagy and suppresses epithelial to mesenchymal transition involving PI3K\/Akt\/mTOR-mediated pathway in human pancreatic cancer cells","volume":"9","author":"Wang","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.phymed.2019.153133_bib0037","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.12659\/MSM.897618","article-title":"Plumbagin mediates cardioprotection against myocardial ischemia\/reperfusion injury through Nrf-2 signaling","volume":"22","author":"Wang","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.phymed.2019.153133_bib0038","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.leukres.2009.08.017","article-title":"Plumbagin induces ROS-mediated apoptosis in human promyelocytic leukemia cells in vivo","volume":"34","author":"Xu","year":"2010","journal-title":"Leuk. Res."},{"key":"10.1016\/j.phymed.2019.153133_bib0039","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1038\/s41598-017-02937-0","article-title":"beta-lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2019.153133_bib0040","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.canlet.2019.03.054","article-title":"The NQO1\/PKLR axis promotes lymph node metastasis and breast cancer progression by modulating glycolytic reprogramming","volume":"453","author":"Yang","year":"2019","journal-title":"Cancer Lett."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711319304490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711319304490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T16:59:06Z","timestamp":1575478746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711319304490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":41,"alternative-id":["S0944711319304490"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2019.153133","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NADPH: Quinone oxidoreductase 1 (NQO1) mediated anti-cancer effects of plumbagin in endocrine resistant MCF7 breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2019.153133","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153133"}}